Award Year / Program / Phase:2008 / STTR / Phase I
Agency:HHS
Research Institution:N/A
Principal Investigator:
Award Amount:$128,100.00
RI Contact:N/A
Abstract:
DESCRIPTION (provided by applicant): There are no FDA approved pharmacological therapies for the acute treatment of traumatic brain injury (TBI) that mitigate damaging neurological effects. However, the potential for effective pharmacological intervention
exists in that a majority of post-traumatic… More